AgeX Therapeutics Inc. (AGE)

AI Score

Unlock

11.10

-1.50 (-11.90%)

At close: Mar 26, 2024, 7:59 PM

AgeX Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018
Period Ending	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018
Cash & Equivalents	8.71M	345K	397K	261K	280K	645K	466K	702K	448K	584K	731K	615K	809K	527K	1.11M	1.03M	468K	2.35M	3.77M	5.81M	8.59M	6.71M	8.76M	11.36M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	10.6M	10.43M	10.25M	10.08M	50K	50K	50K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	50K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	50K	50K	50K	50K	50K	50K	100K	100K	111K	111K	193K	196K	19K	19K	23K	20K
Receivables	65K	57K	71K	6K	6K	4K	1K	12K	n/a	25K	24K	11K	48K	326K	241K	235K	366K	363K	234K	208K	206K	131K	191K	130K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	166K	352K	673K	1.08M	1.46M	1.8M	720K	1.01M	1.38M	1.63M	720K	930K	1.28M	1.43M	581K	836K	1.24M	1.34M	688K	659K	856K	1.01M	222K	200K
Total Current Assets	8.94M	754K	1.14M	1.35M	1.75M	2.45M	1.19M	1.73M	1.83M	2.23M	1.48M	1.56M	2.14M	2.28M	1.93M	2.1M	2.07M	4.05M	4.69M	6.68M	9.65M	7.85M	9.17M	11.69M
Property-Plant & Equipment	1.29M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	442K	681K	898K	1.13M	1.01M	951K	84K	90K	101K	120K
Goodwill & Intangibles	574K	607K	640K	673K	705K	738K	771K	804K	837K	870K	902K	935K	968K	1.59M	1.73M	1.87M	2.01M	2.15M	2.29M	2.43M	2.57M	2.71M	2.85M	1.66M
Total Long-Term Assets	1.92M	11.21M	11.07M	10.93M	10.78M	788K	821K	854K	887K	920K	952K	985K	1.02M	1.64M	2.27M	2.65M	3.02M	3.39M	3.49M	3.58M	2.67M	2.82M	2.97M	1.8M
Total Assets	10.86M	11.96M	12.21M	12.28M	12.53M	3.24M	2.01M	2.58M	2.72M	3.15M	2.43M	2.54M	3.16M	3.92M	4.2M	4.76M	5.09M	7.44M	8.18M	10.26M	12.32M	10.67M	12.14M	13.49M
Account Payables	n/a	1.41M	1.17M	506K	1.26M	841K	612K	509K	919K	771K	723K	1.1M	986K	1.43M	1.53M	1.42M	2.18M	1.32M	1.76M	1.18M	1.02M	1.42M	223K	140K
Deferred Revenue	n/a	1.00	499K	685K	n/a	n/a	n/a	n/a	n/a	70K	272K	293K	283K	275K	255K	328K	407K	283K	219K	266K	361K	317K	n/a	n/a
Short-Term Debt	231K	3.67M	1.53M	22.94M	20.04M	7.65M	7.3M	6.97M	6.66M	7.14M	5.6M	3.56M	2.02M	2.4M	2.43M	2.47M	2.09M	428K	417K	407K	n/a	n/a	n/a	n/a
Other Current Liabilities	13.83M	829K	506K	1.06M	1.22M	1.59M	899K	1.61M	2.52M	1.06M	275K	606K	923K	1.26M	638K	928K	784K	1.27M	514K	776K	915K	707K	1.18M	1.15M
Total Current Liabilities	14.06M	5.91M	3.2M	24.5M	22.52M	10.08M	8.81M	9.09M	10.1M	8.97M	6.6M	5.27M	3.93M	5.36M	4.85M	5.15M	5.47M	3.3M	2.91M	2.63M	2.29M	2.44M	1.41M	1.29M
Long-Term Debt	413K	693K	693K	10.07M	10.01M	10.48M	8.35M	6.76M	4.21M	6.06M	5.81M	5.56M	5.33M	3.9M	3.1M	1.73M	n/a	1.53M	333K	221K	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	693K	n/a	35.96M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	872K	930K
Total Long-Term Liabilities	1.11M	693K	36.65M	10.07M	10.01M	10.48M	8.35M	6.76M	4.21M	6.06M	5.81M	5.56M	5.33M	3.96M	3.1M	1.73M	n/a	1.53M	333K	221K	1.93M	2.12M	872K	930K
Total Liabilities	15.16M	6.61M	39.85M	34.57M	32.54M	20.56M	17.16M	15.84M	14.31M	15.03M	12.4M	10.84M	9.26M	9.32M	7.95M	6.88M	5.47M	4.83M	3.24M	2.85M	2.29M	2.44M	2.28M	2.22M
Total Debt	644K	4.37M	2.22M	33.01M	30.05M	18.12M	15.65M	13.72M	10.87M	13.2M	11.41M	9.12M	7.35M	6.3M	5.52M	4.21M	2.09M	1.96M	750K	628K	n/a	n/a	n/a	n/a
Common Stock	1K	n/a	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	n/a
Retained Earnings	-5.43M	-131.01M	-127.56M	-122.16M	-119.49M	-116.21M	-113.51M	-111.07M	-108.45M	-105.75M	-103.59M	-101.64M	-99.16M	-97.07M	-94.63M	-92.08M	-89.39M	-86.21M	-83.5M	-80.28M	-77.19M	-74.05M	-70.87M	-68.72M
Comprehensive Income	-10.86M	n/a	-21.14M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	143K	92K	81K	44K	69K	74K	44K	24K	-2K	54K	40K
Shareholders Equity	-4.31M	5.47M	-27.54M	-22.18M	-19.89M	-17.21M	-15.1M	-13.22M	-11.55M	-11.83M	-9.94M	-8.25M	-6.06M	-5.12M	-3.65M	-2.44M	-739K	2.22M	4.34M	6.75M	9.32M	7.45M	9.87M	11.27M
Total Investments	n/a	10.6M	10.43M	10.25M	10.08M	50K	50K	50K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a